ME Therapeutics Licenses CD22 Nanobody For In Vivo CAR Cell
16 Oct 2025 //
PHARMIWEB
ME Therapeutics Added To CSE25 Index
10 Oct 2025 //
PHARMIWEB
ME Therapeutics Secures US Patent, Advances Lead Programs
26 Sep 2025 //
BUSINESSWIRE
ME Therapeutics gets Backing for mRNA cancer, inflammatory Diseases
21 May 2025 //
BUSINESSWIRE
Azome Therapeutics Partners with NCATS to Research Inflammation
13 Nov 2024 //
PR NEWSWIRE

Market Place
Sourcing Support